Commentary|Articles|December 9, 2024
ACNP Meeting Highlights Bright Future for Psychiatry
Author(s)Steven P. Levine, MD, Heidi Anne Duerr, MPH
In highlighting recent advances and fostering collaboration and networking, the ACNP Annual Meeting helps usher in 2025 with hope and positivity.
Advertisement
CONFERENCE REPORTER
Psychiatric Times sat down with Steve Levine, MD, psychiatrist and senior vice president of Patient Access and Medical Affairs at Compass Pathways to discuss the 63rd Annual Meeting of the American College of Neuropsychopharmacology, the latest advances in psychiatry, and the reasons the field can be hopeful as we look toward 2025.
Did you attend the ACNP Annual Meeting? What were your highlights? Share your thoughts with us via [email protected]
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Making Sense of the New Alzheimer Treatment Landscape, With Aaron Ritter, MD
2
Real-World and Long-Term Trial Data Show Xanomeline/Trospium Cuts Hospitalizations, Antipsychotic Burden in Schizophrenia
3
July 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
4
A New Mechanism for ADHD: Raman Baweja, MD, on Centanafadine's FDA Approval
5